Osamu Imakyure

418 total citations
36 papers, 305 citations indexed

About

Osamu Imakyure is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Osamu Imakyure has authored 36 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Osamu Imakyure's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Chemical Synthesis and Analysis (3 papers). Osamu Imakyure is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Chemical Synthesis and Analysis (3 papers). Osamu Imakyure collaborates with scholars based in Japan and Canada. Osamu Imakyure's co-authors include M. Hirakawa, Yasufumi Kataoka, Hideki Shuto, Motoyasu Miyazaki, Junichi Matsumoto, Ying Jiang, Takashi Egawa, Takashi Yanagawa, Masanobu Uchiyama and Hitoshi Nohta and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytica Chimica Acta.

In The Last Decade

Osamu Imakyure

28 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Imakyure Japan 10 65 47 41 38 37 36 305
R. J. E. Grouls Netherlands 15 37 0.6× 71 1.5× 10 0.2× 41 1.1× 78 2.1× 51 567
Byung Koo Lee South Korea 10 65 1.0× 42 0.9× 9 0.2× 57 1.5× 88 2.4× 20 358
Piotr Dylewicz Poland 11 123 1.9× 36 0.8× 25 0.6× 19 0.5× 6 0.2× 27 386
Cui Yi-min China 12 63 1.0× 47 1.0× 2 0.0× 61 1.6× 13 0.4× 36 405
Deborah S. King United States 10 40 0.6× 108 2.3× 5 0.1× 22 0.6× 12 0.3× 16 476
Suzanne V. Frankfort Netherlands 11 36 0.6× 31 0.7× 2 0.0× 70 1.8× 164 4.4× 15 367
Katrin Christiane Reber Germany 10 28 0.4× 19 0.4× 6 0.1× 15 0.4× 28 0.8× 37 262
Alexander J. Lawson United Kingdom 11 64 1.0× 59 1.3× 27 0.7× 18 0.5× 17 357
Małgorzata Ostrowska Poland 14 366 5.6× 22 0.5× 13 0.3× 34 0.9× 9 0.2× 43 555
Brian J. Gates United States 10 42 0.6× 51 1.1× 1 0.0× 47 1.2× 107 2.9× 28 369

Countries citing papers authored by Osamu Imakyure

Since Specialization
Citations

This map shows the geographic impact of Osamu Imakyure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Imakyure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Imakyure more than expected).

Fields of papers citing papers by Osamu Imakyure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Imakyure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Imakyure. The network helps show where Osamu Imakyure may publish in the future.

Co-authorship network of co-authors of Osamu Imakyure

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Imakyure. A scholar is included among the top collaborators of Osamu Imakyure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Imakyure. Osamu Imakyure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Motoyasu, et al.. (2025). Pharmacist-Led Prevention of Recurrent Cetuximab Infusion Reactions. Cureus. 17(11). e97871–e97871.
2.
3.
Uchiyama, Masanobu, Motoyasu Miyazaki, Toshinobu Hayashi, et al.. (2024). Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study. Journal of Geriatric Oncology. 15(6). 101814–101814.
4.
5.
Nakashima, Akio, et al.. (2024). Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis. Journal of Pharmaceutical Health Care and Sciences. 10(1). 1 indexed citations
6.
Miyazaki, Motoyasu, et al.. (2023). Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with Clostridioides difficile Infection. Antibiotics. 12(3). 428–428. 1 indexed citations
7.
Miyazaki, Motoyasu, et al.. (2023). Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study. Journal of Clinical Medicine. 12(24). 7564–7564. 7 indexed citations
8.
Miyazaki, Motoyasu, Hisako Kushima, Masanobu Uchiyama, et al.. (2022). Association between disease severity according to “MN criteria” and 30-day mortality in patients with Clostridioides difficile infection. Journal of Infection and Chemotherapy. 28(6). 757–761. 1 indexed citations
9.
Miyazaki, Motoyasu, Masanobu Uchiyama, Yoshihiko Nakamura, et al.. (2020). Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study. Journal of Pharmaceutical Health Care and Sciences. 6(1). 2–2. 18 indexed citations
10.
Uchiyama, Masanobu, et al.. (2020). Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital. BMC Health Services Research. 20(1). 1017–1017. 6 indexed citations
11.
Miyazaki, Motoyasu, Masanobu Uchiyama, Nobuhiko Nagata, et al.. (2019). Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli. Journal of Clinical Medicine Research. 11(9). 635–641. 12 indexed citations
12.
Miyazaki, Motoyasu, Akio Nakashima, Yoshihiko Nakamura, et al.. (2018). Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study. PLoS ONE. 13(9). e0204814–e0204814. 43 indexed citations
13.
Kozako, Tomohiro, Shuhei Soeda, Makoto Yoshimitsu, et al.. (2016). Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T‐cell leukemia cells. FEBS Open Bio. 6(5). 442–460. 33 indexed citations
14.
Hayama, Tadashi, et al.. (2016). Fluorous-assisted metal chelate affinity extraction technique for analysis of protein kinase activity. Talanta. 156-157. 1–5. 3 indexed citations
15.
Nakano, Takafumi, Yoshihiko Nakamura, Tohru Takata, et al.. (2016). Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis. International Journal of Clinical Pharmacy. 38(4). 908–914. 7 indexed citations
16.
Hayama, Tadashi, et al.. (2015). Direct tandem mass spectrometric analysis of amino acids in plasma using fluorous derivatization and monolithic solid-phase purification. Journal of Pharmaceutical and Biomedical Analysis. 115. 201–207. 10 indexed citations
17.
Yoshida, Hideyuki, Tadashi Hayama, Kenichiro Todoroki, et al.. (2015). Selective and sensitive liquid chromatographic determination method of 5-hydroxyindoles with fluorous and fluorogenic derivatization. Journal of Pharmaceutical and Biomedical Analysis. 114. 348–354. 11 indexed citations
18.
Imakyure, Osamu, et al.. (2010). Analysis of Clinical Pharmacist Interventions in Intensive Care Unit. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36(9). 674–679. 3 indexed citations
19.
Shuto, Hideki, Osamu Imakyure, Junichi Matsumoto, et al.. (2010). Medication use as a risk factor for inpatient falls in an acute care hospital: a case‐crossover study. British Journal of Clinical Pharmacology. 69(5). 535–542. 76 indexed citations
20.
Imakyure, Osamu, et al.. (2009). Development of Practical Clinical Trials Education Program for Pharmacy Students. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(9). 636–643. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. J. E. Grouls Breakdown of academic impact, for papers by Byung Koo Lee Breakdown of academic impact, for papers by Piotr Dylewicz Breakdown of academic impact, for papers by Cui Yi-min Breakdown of academic impact, for papers by Deborah S. King Breakdown of academic impact, for papers by Suzanne V. Frankfort Breakdown of academic impact, for papers by Katrin Christiane Reber Breakdown of academic impact, for papers by Alexander J. Lawson Breakdown of academic impact, for papers by Małgorzata Ostrowska Breakdown of academic impact, for papers by Brian J. Gates
Rankless by CCL
2026